AAAAAA

   
Results: 1-25 | 26-50 | 51-75 | 76-77
Results: 1-25/77
PHYSIOPATHOLOGY OF IL-12 IN HUMAN SOLID NEOPLASMS - BLOOD-LEVELS OF IL-12 IN EARLY OR ADVANCED CANCER-PATIENTS, AND THEIR VARIATIONS WITH SURGERY AND IMMUNOTHERAPY
Authors: LISSONI P MENGO S MANDALA M MAURI E BRIVIO F ROVELLI F CONFALONIERI G LONGARINI R BONFANTE A FOLLI D MEREGALLI S BARNI S TANCINI G GIANI L
Citation: P. Lissoni et al., PHYSIOPATHOLOGY OF IL-12 IN HUMAN SOLID NEOPLASMS - BLOOD-LEVELS OF IL-12 IN EARLY OR ADVANCED CANCER-PATIENTS, AND THEIR VARIATIONS WITH SURGERY AND IMMUNOTHERAPY, Journal of biological regulators and homeostatic agents, 12(1-2), 1998, pp. 38-41
NEOADJUVANT CHEMOTHERAPY TO RADIATION AND CONCURRENT CHEMORADIATION FOR LOCALLY ADVANCED SQUAMOUS-CELL CARCINOMA OF THE CERVIX - A REVIEW OF THE RECENT LITERATURE
Authors: COLOMBO A LANDONI F MANEO A ZANETTA G NAVA S TANCINI G
Citation: A. Colombo et al., NEOADJUVANT CHEMOTHERAPY TO RADIATION AND CONCURRENT CHEMORADIATION FOR LOCALLY ADVANCED SQUAMOUS-CELL CARCINOMA OF THE CERVIX - A REVIEW OF THE RECENT LITERATURE, Tumori, 84(2), 1998, pp. 229-237
CLINICAL EFFICACY OF THE AROMATASE INHIBITOR ANASTROZOLE IN RELATION TO PROLACTIN SECRETION IN HEAVILY PRETREATED METASTATIC BREAST-CANCER
Authors: BARNI S LISSONI P MEREGALLI S ARDIZZOIA A MENGO S MUSCO F MERLINI D TANCINI G
Citation: S. Barni et al., CLINICAL EFFICACY OF THE AROMATASE INHIBITOR ANASTROZOLE IN RELATION TO PROLACTIN SECRETION IN HEAVILY PRETREATED METASTATIC BREAST-CANCER, Tumori, 84(1), 1998, pp. 45-47
EFFECT OF INTERLEUKIN-12 IMMUNOTHERAPY ON ENDOGENOUS SECRETION OF INTERLEUKIN-2 IN METASTATIC CANCER-PATIENTS
Authors: LISSONI P MANDALA M ROVELLI F GIANI L BARNI S MAURI E TANCINI G FUMAGALLI L DIFELICE G MAIORCA F MEREGALLI S
Citation: P. Lissoni et al., EFFECT OF INTERLEUKIN-12 IMMUNOTHERAPY ON ENDOGENOUS SECRETION OF INTERLEUKIN-2 IN METASTATIC CANCER-PATIENTS, International journal of immunotherapy, 14(2), 1998, pp. 101-104
IMMUNOBIOLOGICAL EFFECTS OF INTERLEUKIN-2, INTERLEUKIN-12 OR INTERLEUKIN-2 PLUS INTERLEUKIN-12 IN METASTATIC CANCER-PATIENTS
Authors: LISSONI P BARNI S MANDALA M ROVELLI F CANGEMI G FUMAGALLI L PIRATO D VIGORE L ROSELLI MG TANCINI G VIGANO MG GIANI L
Citation: P. Lissoni et al., IMMUNOBIOLOGICAL EFFECTS OF INTERLEUKIN-2, INTERLEUKIN-12 OR INTERLEUKIN-2 PLUS INTERLEUKIN-12 IN METASTATIC CANCER-PATIENTS, International journal of immunotherapy, 14(1), 1998, pp. 41-44
IMMUNOTHERAPY WITH LOW-DOSE INTERLEUKIN-2 IN ASSOCIATION WITH MELATONIN AS SALVAGE THERAPY FOR METASTATIC SOFT-TISSUE SARCOMAS
Authors: LISSONI P BARNI S ARDIZZOIA A TANCINI G
Citation: P. Lissoni et al., IMMUNOTHERAPY WITH LOW-DOSE INTERLEUKIN-2 IN ASSOCIATION WITH MELATONIN AS SALVAGE THERAPY FOR METASTATIC SOFT-TISSUE SARCOMAS, Oncology Reports, 4(1), 1997, pp. 157-159
ACUTE EFFECTS OF PAMIDRONATE ADMINISTRATION ON SERUM LEVELS OF INTERLEUKIN-6 IN ADVANCED SOLID TUMOR PATIENTS WITH BONE METASTASES AND THEIR POSSIBLE IMPLICATIONS IN THE IMMUNOTHERAPY OF CANCER WITH INTERLEUKIN-2
Authors: LISSONI P CAZZANIGA M BARNI S PEREGO MS BRIVIO F FUMAGALLI L TANCINI G
Citation: P. Lissoni et al., ACUTE EFFECTS OF PAMIDRONATE ADMINISTRATION ON SERUM LEVELS OF INTERLEUKIN-6 IN ADVANCED SOLID TUMOR PATIENTS WITH BONE METASTASES AND THEIR POSSIBLE IMPLICATIONS IN THE IMMUNOTHERAPY OF CANCER WITH INTERLEUKIN-2, European journal of cancer, 33(2), 1997, pp. 304-306
TREATMENT OF CANCER CHEMOTHERAPY-INDUCED TOXICITY WITH THE PINEAL HORMONE MELATONIN
Authors: LISSONI P TANCINI G BARNI S PAOLOROSSI F ARDIZZOIA A CONTI A MAESTRONI G
Citation: P. Lissoni et al., TREATMENT OF CANCER CHEMOTHERAPY-INDUCED TOXICITY WITH THE PINEAL HORMONE MELATONIN, Supportive care in cancer, 5(2), 1997, pp. 126-129
A RANDOMIZED STUDY OF CHEMOTHERAPY WITH CISPLATIN PLUS ETOPOSIDE VERSUS CHEMOENDOCRINE THERAPY WITH CISPLATIN, ETOPOSIDE AND THE PINEAL HORMONE MELATONIN AS A FIRST-LINE TREATMENT OF ADVANCED NONSMALL CELL LUNG-CANCER PATIENTS IN A POOR CLINICAL STATE
Authors: LISSONI P PAOLOROSSI F ARDIZZOIA A BARNI S CHILELLI M MANCUSO M TANCINI G CONTI A MAESTRONI GJM
Citation: P. Lissoni et al., A RANDOMIZED STUDY OF CHEMOTHERAPY WITH CISPLATIN PLUS ETOPOSIDE VERSUS CHEMOENDOCRINE THERAPY WITH CISPLATIN, ETOPOSIDE AND THE PINEAL HORMONE MELATONIN AS A FIRST-LINE TREATMENT OF ADVANCED NONSMALL CELL LUNG-CANCER PATIENTS IN A POOR CLINICAL STATE, Journal of pineal research, 23(1), 1997, pp. 15-19
ACUTE ENDOCRINE EFFECTS OF INTERLEUKIN-12 IN CANCER-PATIENTS
Authors: LISSONI P ROVELLI F RIVOLTA MR FRIGERIO C MANDALA M BARNI S ARDIZZOIA A MALUGANI F TANCINI G
Citation: P. Lissoni et al., ACUTE ENDOCRINE EFFECTS OF INTERLEUKIN-12 IN CANCER-PATIENTS, Journal of biological regulators and homeostatic agents, 11(4), 1997, pp. 154-156
REVERSAL OF CLINICAL RESISTANCE TO LHRH ANALOG IN METASTATIC PROSTATE-CANCER BY THE PINEAL HORMONE MELATONIN - EFFICACY OF LHRH ANALOG PLUSMELATONIN IN PATIENTS PROGRESSING ON LHRH ANALOG ALONE
Authors: LISSONI P CAZZANIGA M TANCINI G SCARDINO E MUSCI R BARNI S MAFFEZZINI M MERONI T ROCCO F CONTI A MAESTRONI G
Citation: P. Lissoni et al., REVERSAL OF CLINICAL RESISTANCE TO LHRH ANALOG IN METASTATIC PROSTATE-CANCER BY THE PINEAL HORMONE MELATONIN - EFFICACY OF LHRH ANALOG PLUSMELATONIN IN PATIENTS PROGRESSING ON LHRH ANALOG ALONE, European urology, 31(2), 1997, pp. 178-181
PROGNOSTIC-SIGNIFICANCE OF CHANGES IN IL-12 SECRETION DURING CANCER-IMMUNOTHERAPY WITH IL-2 - PRELIMINARY CONSIDERATIONS
Authors: LISSONI P FUMAGALLI L DIFELICE G MENGO S MAURI E MERLINI D MEREGALLI S ROVELLI F BARNI S TANCINI G
Citation: P. Lissoni et al., PROGNOSTIC-SIGNIFICANCE OF CHANGES IN IL-12 SECRETION DURING CANCER-IMMUNOTHERAPY WITH IL-2 - PRELIMINARY CONSIDERATIONS, International journal of immunotherapy, 13(1-2), 1997, pp. 17-23
TUMOR-NECROSIS-FACTOR-ALPHA (TNF-ALPHA) BLOOD-LEVELS IN RELATION TO THE ACTIVITY OF THE PINEAL-GLAND IN CANCER-PATIENTS
Authors: LISSONI P BRIVIO F BARNI S TANCINI G ARDIZZOIA A ROVELLI F GRAMAZIO P ALDERI G ZUBELEWICZ B
Citation: P. Lissoni et al., TUMOR-NECROSIS-FACTOR-ALPHA (TNF-ALPHA) BLOOD-LEVELS IN RELATION TO THE ACTIVITY OF THE PINEAL-GLAND IN CANCER-PATIENTS, Biologicals, 24(3), 1996, pp. 214-214
IMMUNOTHERAPY WITH SUBCUTANEOUS LOW-DOSE INTERLEUKIN-2 PLUS MELATONINAS SALVAGE THERAPY OF HEAVILY CHEMOTHERAPY-PRETREATED OVARIAN-CANCER
Authors: LISSONI P ARDIZZOIA A BARNI S TANCINI G MUTTINI MP
Citation: P. Lissoni et al., IMMUNOTHERAPY WITH SUBCUTANEOUS LOW-DOSE INTERLEUKIN-2 PLUS MELATONINAS SALVAGE THERAPY OF HEAVILY CHEMOTHERAPY-PRETREATED OVARIAN-CANCER, Oncology Reports, 3(5), 1996, pp. 947-949
IS THERE A ROLE FOR MELATONIN IN THE TREATMENT OF NEOPLASTIC CACHEXIA
Authors: LISSONI P PAOLOROSSI F TANCINI G BARNI S ARDIZZOIA A BRIVIO F ZUBELEWICZ B CHATIKHINE V
Citation: P. Lissoni et al., IS THERE A ROLE FOR MELATONIN IN THE TREATMENT OF NEOPLASTIC CACHEXIA, European journal of cancer, 32A(8), 1996, pp. 1340-1343
PREVENTION OF CYTOKINE-INDUCED HYPOTENSION IN CANCER-PATIENTS BY THE PINEAL HORMONE MELATONIN
Authors: LISSONI P PITTALIS S ARDIZZOIA A BRIVIO F BARNI S TANCINI G PELIZZONI F MAESTRONI GJM ZUBELEWICZ B BRACZKOWSKI R
Citation: P. Lissoni et al., PREVENTION OF CYTOKINE-INDUCED HYPOTENSION IN CANCER-PATIENTS BY THE PINEAL HORMONE MELATONIN, Supportive care in cancer, 4(4), 1996, pp. 313-316
ADJUVANT THERAPY WITH THE PINEAL HORMONE MELATONIN IN PATIENTS WITH LYMPH-NODE RELAPSE DUE TO MALIGNANT-MELANOMA
Authors: LISSONI P BRIVIO O BRIVIO F BARNI S TANCINI G CRIPPA D MEREGALLI S
Citation: P. Lissoni et al., ADJUVANT THERAPY WITH THE PINEAL HORMONE MELATONIN IN PATIENTS WITH LYMPH-NODE RELAPSE DUE TO MALIGNANT-MELANOMA, Journal of pineal research, 21(4), 1996, pp. 239-242
REACTIVATION OF A NORMAL ENDOGENOUS SECRETION OF INTERLEUKIN-2 IN METASTATIC CANCER-PATIENTS BY A CHRONIC SUBCUTANEOUS INJECTION OF INTERLEUKIN-2
Authors: DIFELICE G FUMAGALLI L MAJORCA F BARNI S ARDIZZOIA A TANCINI G LISSONI P
Citation: G. Difelice et al., REACTIVATION OF A NORMAL ENDOGENOUS SECRETION OF INTERLEUKIN-2 IN METASTATIC CANCER-PATIENTS BY A CHRONIC SUBCUTANEOUS INJECTION OF INTERLEUKIN-2, Journal of biological regulators and homeostatic agents, 10(4), 1996, pp. 98-99
CLINICAL-SIGNIFICANCE OF ERYTHROSEDIMENTATION RATE IN CANCER IN RELATION TO CYTOKINE PRODUCTION - CORRELATION WITH HIGH IL-6 AND LOW IL-2 BLOOD-CONCENTRATIONS
Authors: LISSONI P BRIVIO F PITTALIS S ROVELLI F RESCALDANI R PEREGO MS GRASSI MG BARNI S TANCINI G MAJORCA F FUMAGALLI L
Citation: P. Lissoni et al., CLINICAL-SIGNIFICANCE OF ERYTHROSEDIMENTATION RATE IN CANCER IN RELATION TO CYTOKINE PRODUCTION - CORRELATION WITH HIGH IL-6 AND LOW IL-2 BLOOD-CONCENTRATIONS, Journal of biological regulators and homeostatic agents, 10(2-3), 1996, pp. 60-62
EFFECTS OF ONE-YEAR ADJUVANT TREATMENT WITH TAMOXIFEN ON BONE-MINERALDENSITY IN POSTMENOPAUSAL BREAST-CANCER WOMEN
Authors: BARNI S LISSONI P TANCINI G ARDIZZOIA A CAZZANIGA M
Citation: S. Barni et al., EFFECTS OF ONE-YEAR ADJUVANT TREATMENT WITH TAMOXIFEN ON BONE-MINERALDENSITY IN POSTMENOPAUSAL BREAST-CANCER WOMEN, Tumori, 82(1), 1996, pp. 65-67
CHARACTERIZATION OF CANCER-RELATED DISSEMINATED INTRAVASCULAR COAGULATION IN RELATION TO TUMOR-NECROSIS-FACTOR-ALPHA BLOOD-CONCENTRATIONS -POSSIBLE THERAPEUTIC ROLE OF PENTOXIFYLLINE
Authors: LISSONI P ARDIZZOIA A BARNI S PITTALIS S ROSSINI F PORTA A TANCINI G
Citation: P. Lissoni et al., CHARACTERIZATION OF CANCER-RELATED DISSEMINATED INTRAVASCULAR COAGULATION IN RELATION TO TUMOR-NECROSIS-FACTOR-ALPHA BLOOD-CONCENTRATIONS -POSSIBLE THERAPEUTIC ROLE OF PENTOXIFYLLINE, Tumori, 82(1), 1996, pp. 78-80
BIOLOGICAL SIGNIFICANCE OF INTERLEUKIN-6 SECRETION ON CANCER-IMMUNOTHERAPY WITH INTERLEUKIN-2
Authors: LISSONI P FUMAGALLI L BARNI S DIFELICE G ARDIZZOIA A MAIORCA F TANCINI G
Citation: P. Lissoni et al., BIOLOGICAL SIGNIFICANCE OF INTERLEUKIN-6 SECRETION ON CANCER-IMMUNOTHERAPY WITH INTERLEUKIN-2, International journal of immunotherapy, 12(3-4), 1996, pp. 49-52
CONCURRENT PREOPERATIVE CHEMOTHERAPY WITH 5-FLUOROURACIL AND MITOMYCIN-C AND RADIOTHERAPY (FUMIR) FOLLOWED BY LIMITED SURGERY IN LOCALLY ADVANCED AND RECURRENT VULVAR CARCINOMA
Authors: LANDONI F MANEO A ZANETTA G COLOMBO A NAVA S PLACA F TANCINI G MANGIONI C
Citation: F. Landoni et al., CONCURRENT PREOPERATIVE CHEMOTHERAPY WITH 5-FLUOROURACIL AND MITOMYCIN-C AND RADIOTHERAPY (FUMIR) FOLLOWED BY LIMITED SURGERY IN LOCALLY ADVANCED AND RECURRENT VULVAR CARCINOMA, Gynecologic oncology, 61(3), 1996, pp. 321-327
INCREASED SURVIVAL-TIME IN BRAIN GLIOBLASTOMAS BY A RADIONEUROENDOCRINE STRATEGY WITH RADIOTHERAPY PLUS MELATONIN COMPARED TO RADIOTHERAPY ALONE
Authors: LISSONI P MEREGALLI S NOSETTO L BARNI S TANCINI G FOSSATI V MAESTRONI G
Citation: P. Lissoni et al., INCREASED SURVIVAL-TIME IN BRAIN GLIOBLASTOMAS BY A RADIONEUROENDOCRINE STRATEGY WITH RADIOTHERAPY PLUS MELATONIN COMPARED TO RADIOTHERAPY ALONE, Oncology, 53(1), 1996, pp. 43-46
A PHASE-II STUDY OF TAMOXIFEN PLUS MELATONIN IN METASTATIC SOLID TUMOR PATIENTS
Authors: LISSONI P PAOLOROSSI F TANCINI G ARDIZZOIA A BARNI S BRIVIO F MAESTRONI GJM CHILELLI M
Citation: P. Lissoni et al., A PHASE-II STUDY OF TAMOXIFEN PLUS MELATONIN IN METASTATIC SOLID TUMOR PATIENTS, British Journal of Cancer, 74(9), 1996, pp. 1466-1468
Risultati: 1-25 | 26-50 | 51-75 | 76-77